◆英語タイトル：Hypera SA - Strategy, SWOT and Corporate Finance Report
◆商品コード：DATA904C6904
◆発行会社（調査会社）：
MarketLine
◆発行日：2018年10月
◆ページ数：21
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：ブラジル
◆産業分野：製薬・医療
◆販売価格オプション（消費税別）
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
MarketLine社の概要はこちらでご確認いただけます。
Hypera SA – Strategy, SWOT and Corporate Finance Report
Summary
Hypera SA – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Key Highlights
Hypera SA (Hypera) formerly, Hypermarcas SA, is a manufacturer of pharmaceutical products. It primarily offers non-prescription (OTC) drugs, prescribed medications, branded, generics and sweeteners. The company markets its products under various brands including Addera D3, Alivium, Benegrip, Biotonico Fontoura, Doril, Engov, Epocler, Predsim, Neo Quimica Zero-Cal and Finn. Its products are distributed through distributors and wholesalers across Brazil. The company operates through its subsidiary, Brainfarma Industria Quimica e Farmaceutica S.A. It operates distribution centers in Anapolis and Goiania, Brazil. Hypera is headquartered in Sao Paulo, Brazil.
Scope
- Detailed information on Hypera SA required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Hypera SA in the form of a SWOT analysis
- An in-depth view of the business model of Hypera SA including a breakdown and examination of key business segments
- Intelligence on Hypera SA’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Hypera SA, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to buy
- Gain understanding of Hypera SA and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Hypera SA as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Hypera SA’s business structure, strategy and prospects.
Table of Contents
Company Snapshot 2
Table of Contents 4
Hypera SA: Company Overview 6
Hypera SA: Overview and Key Facts 6
Hypera SA: Overview 6
Hypera SA: Key Facts 6
Hypera SA: Key Employees 8
Hypera SA: Major Products and Services 9
Hypera SA: Company History 10
Hypera SA: Locations and Subsidiaries 12
Hypera SA: Key Competitors 13
Hypera SA: Company Analysis 14
Hypera SA: Business Description 14
Hypera SA: SWOT Analysis 15
Hypera SA: SWOT Overview 15
Hypera SA: Strengths 15
Hypera SA: Weaknesses 16
Hypera SA: Opportunities 16
Hypera SA: Threats 17
Hypera SA: Recent Developments 18
Hypera SA: News and Events Summary 18
Hypera SA: Research & Development 18
Appendix 19
Contact Us 19
Methodology 19
About MarketLine 20
List of Tables
Table 1: Hypera SA: Key Facts
Table 2: Hypera SA: Key Employees
Table 3: Hypera SA: Company History
Table 4: Hypera SA: Locations and Subsidiaries
Table 5: Hypera SA: Key Competitors
Table 6: Hypera SA: News and Events Summary
Table 7: Hypera SA: Research & Development
